Let’s start up with the current stock price of Takeda Pharmaceutical Company Limited (TAK), which is $16.36 to be very precise. The Stock rose vividly during the last session to $16.09 after opening rate of $16.03 while the lowest price it went was recorded $15.97 before closing at $16.08.
Takeda Pharmaceutical Company Limited had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $16.40 on 03/16/23, with the lowest value was $12.28 for the same time period, recorded on 10/21/22.
Top 5 EV Tech Stocks to Buy for 2023
According a new report published by BloombergNEF on investment in the energy transition, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now.
Click Here to Download the FREE Report.
Sponsored
Takeda Pharmaceutical Company Limited (TAK) full year performance was 12.93%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Takeda Pharmaceutical Company Limited shares are logging 0.39% during the 52-week period from high price, and 33.25% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $12.28 and $16.30.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 1590446 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Takeda Pharmaceutical Company Limited (TAK) recorded performance in the market was 4.89%, having the revenues showcasing 7.37% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 51.20B, as it employees total of 47347 workers.
The Analysts eye on Takeda Pharmaceutical Company Limited (TAK)
During the last month, 5 analysts gave the Takeda Pharmaceutical Company Limited a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 9 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 15.06, with a change in the price was noted +3.86. In a similar fashion, Takeda Pharmaceutical Company Limited posted a movement of +30.92% for the period of last 100 days, recording 2,730,484 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for TAK is recording 0.69 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.63.
Technical rundown of Takeda Pharmaceutical Company Limited (TAK)
Raw Stochastic average of Takeda Pharmaceutical Company Limited in the period of last 50 days is set at 97.33%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 97.33%. In the last 20 days, the company’s Stochastic %K was 92.44% and its Stochastic %D was recorded 85.37%.
Considering, the past performance of Takeda Pharmaceutical Company Limited, multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 4.89%. Additionally, trading for the stock in the period of the last six months notably improved by 22.30%, alongside a boost of 12.93% for the period of the last 12 months. The shares increased approximately by 2.21% in the 7-day charts and went down by 2.79% in the period of the last 30 days. Common stock shares were driven by 7.37% during last recorded quarter.
